Merck now has bio approval

[anonymous]

Add this to the basal market and with Januvia running near the end of its life cycle they will put a great deal of emphasis on this product. I know that bodes well for us because our leadership manages to deal exceptionally well with competitive environments. Future look bright for diabetes.

 

[anonymous]

That is not unexpected. Now we wait to see how aggressive Lilly is with basaglar in the coming wave of formulary updates to try and keep Merck from playing in their sandbox until the end of 2018. Or, heaven forbid, Novo does a deal with Merck to offer a full portfolio of products to combat the Lilly advantage.

Meanwhile, Lantus will continue to sink slowly below the waves. By end of 2018 only the smokestacks will be visible above the water line. Sucks to have an empty pipeline.

 

[anonymous]

Luckily for us we have coupons and managed care spreadsheets and managers who whip our eyes.

Luckily the goals are hard to reach.

Toujeo = Sanofi new Coke.

Sanofi is a dumpster fire, a rabid squirrel, a fart in church, a swine farm in Yemen, a roll of cheap toilet paper, a dog rubbing his anus on the carpet, no matter how many times you shake it, it's the drops of pee pee that leak thru your kacky pants.

Oops. I told the truth.

 

[anonymous]

Lol- a perfect analogy of what Sanofi has become. Could management fuck this company up anymore with their lack of vision and reaction to the market and their planning . Sanofi managed care is a joke

 

[anonymous]

Add this to the basal market and with Januvia running near the end of its life cycle they will put a great deal of emphasis on this product. I know that bodes well for us because our leadership manages to deal exceptionally well with competitive environments. Future look bright for diabetes.

darn you! Just got these high end shorts out of the cleaner. Now there is spit-out coffee on em

THAT POST WAS BRILLIANT